Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.

Also called NCT03426982

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03426982
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03426982. Randomized; no masking; primary purpose supportive care. Start 2018-03-01 (actual); primary completion 2018-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
Acronym
CATCH
Condition
Venous Thromboembolism
Condition
Stroke
Condition
Bleeding
Intervention (Drug)
Unfractionated heparin
Intervention (Drug)
Unfractionated heparin
Lead sponsor
Wuhan Asia Heart Hospital (class: other)

Record details

Record id
cardio:ct-nct03426982
Content hash
c8dc95453b5a73dbbcde96c2f236b8b93f760233cac418e405e9cb3681c4299b